YoungJa Lee
Overview
Explore the profile of YoungJa Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheon J, Kim H, Han D, Kim S, Shin S, Kim J, et al.
Gut Liver
. 2022 Dec;
17(5):777-785.
PMID: 36578194
Background/aims: To date, there is no prospective study that specifically investigated the efficacy of infliximab in intestinal Behçet's disease (BD). This study evaluated the efficacy of infliximab in patients with...
2.
Son S, Yu D, Kim Y, Ahn H, Jang Y, Roh J, et al.
Ann Dermatol
. 2022 Feb;
34(1):14-21.
PMID: 35221590
Background: In psoriasis treatment, not all body regions improve simultaneously after clinical interventions. Objective: This study was aimed at evaluating clinical responses across body regions, which may differentially influence patient...
3.
Kim H, Kim Y, Lee Y
Rheumatol Ther
. 2021 Jul;
8(3):1393-1404.
PMID: 34324171
Introduction: Golimumab is a human monoclonal antibody that inhibits tumor necrosis factor-α (TNF-α). Inhibition of TNF-α by golimumab inhibits the inflammatory response, thereby modulating the immune response in immune-mediated inflammatory...
4.
Yoon J, Cha J, Lee C, Park Y, Huh K, Shin J, et al.
J Gastroenterol Hepatol
. 2021 Feb;
36(8):2149-2156.
PMID: 33555067
Background And Aim: No inception cohort study has ever evaluated the early course of moderate-to-severe ulcerative colitis (UC) within 1 year of diagnosis in the non-Caucasian population. We aimed to...
5.
Youn S, Yu D, Kim B, Kim Y, Kim K, Choi J, et al.
J Dermatol
. 2021 Feb;
48(6):778-785.
PMID: 33528054
Postmarketing surveillance is conducted to establish drug safety and effectiveness under real-world practice. We aimed to validate the effectiveness and safety of ustekinumab in the treatment of adult Korean patients...
6.
Youn S, Yu D, Kim T, Kim B, Lee S, Lee J, et al.
J Dermatolog Treat
. 2020 May;
33(1):535-541.
PMID: 32419536
Background: The phase 3 studies, VOYAGE 1 and 2, were conducted to assess guselkumab in the treatment of patients with moderate-to-severe psoriasis. Objectives: To investigate the efficacy and safety of...
7.
Li C, Han H, Lee J, Lee M, Lee Y, Kim M
Asian Nurs Res (Korean Soc Nurs Sci)
. 2014 Jul;
4(3):122-9.
PMID: 25031093
Purpose: The aim of the study was to assess the prevalence, knowledge and behavior about reproductive tract infections (RTIs) among rural Chinese women in Hunchun, China. Methods: The study employed...